Building a European capital market
Interviewee/Contributor
William Ellington
Organisation
Evernow Publishing Ltd
Research Directory
The new complexity in clinical study protocols
Interviewee/ContributorShiva MemariOrganisationVertical KnowingCell therapy success and the competition for value
Interviewee/ContributorMiguel ForteOrganisationZelluna Immunotherapy ASWhy pharma is paying a premium for assets
Interviewee/ContributorTim Sturgeon and Martin GouldstoneOrganisationResults HealthcareTakeovers refocus Sanofi on rare diseases
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundHow GMO rules affect gene and cell therapies
Interviewee/ContributorHouria BachtarziOrganisationERA Consulting (UK) LtdThe advance of digital medicine
Interviewee/ContributorJean-Claude MullerOrganisationMedNousRemotely controlling gene expression
Interviewee/ContributorMartin FusseneggerOrganisationETH ZürichPixium Vision: A strategy for treating macular degeneration
Interviewee/ContributorKhalid IshaqueOrganisationPixium Vision SAThe impact of digital technology on diagnostics
Interviewee/ContributorJohn LinOrganisationGE Healthcare